Erratum: Can we reduce negative blood cultures with clinical scores and blood markers? Results from an observational cohort study (Medicine 94: 49 (e2264) DOI: 10.1097/MD.0000000000002264);Can we reduce negative blood cultures with clinical scores and blood markers? results from an observational cohort study

Medicine (United States)

Volumn 94, Issue 49, 2015, Pages

  Laukemann, Svenja ^a   Kasper, Nina ^a   Kulkarni, Prasad ^b   Steiner, Deborah ^a   Rast, Anna Christina ^a   Kutz, Alexander ^a   Felder, Susan ^a   Haubitz, Sebastian ^c   Faessler, Lukas ^a,d   Huber, Andreas ^e   Fux, Christoph A ^f   Mueller, Beat ^a   Schuetz, Philipp ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b Asclepius Medical Communications LLC   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY OF BERN   (Switzerland)

^e Department of Laboratory Medicine ^*  (China)

^f Clinic of Infectious Diseases   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; PROCALCITONIN; CALCITONIN; PROTEIN PRECURSOR;

ADULT; AGED; ARTICLE; BLOOD CULTURE; CLINICAL ASSESSMENT; COHORT ANALYSIS; ERYTHROCYTE; FEMALE; HOSPITAL ADMISSION; HUMAN; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL LYMPHOCYTE RATIO; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCORING SYSTEM; BACTEREMIA; BLOOD; LABORATORY DIAGNOSIS; LYMPHOCYTE; MICROBIOLOGICAL EXAMINATION; MIDDLE AGED; NEUTROPHIL; PROCEDURES; PROSPECTIVE STUDY;

AGED; BACTEREMIA; BACTERIOLOGICAL TECHNIQUES; BIOMARKERS; C-REACTIVE PROTEIN; CALCITONIN; ERYTHROCYTES; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; LEUKOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS;

EID: 84952649380     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000006197     Document Type: Erratum

References (36)

1. Coburn B, Morris AM, Tomlinson G, et al. Does this adult patient with suspected bacteremia require blood cultures? JAMA. 2012;308:502-511.
2. Schuetz P, Mueller B, Trampuz A. Serum procalcitonin for discrimination of blood contamination from bloodstream infection due to coagulase-negative staphylococci. Infection. 2007;35:352-355.
3. Shapiro NI, Wolfe RE, Wright SB, et al. Who needs a blood culture? A prospectively derived and validated prediction rule. J Emerg Med. 2008;35:255-264.
4. Jessen MK, Mackenhauer J, Hvass AM, et al. Prediction of bacteremia in the emergency department: an external validation of a clinical decision rule. Eur J Emerg Med. 2014[Epub ahead of print].
5. Lee J, Hwang SS, Kim K, et al. Bacteremia prediction model using a common clinical test in patients with community-acquired pneumonia. Am J Emerg Med. 2014;32:700-704.
6. Jones GR, Lowes JA. The systemic inflammatory response syndrome as a predictor of bacteraemia and outcome from sepsis. QJM. 1996;89:515-522.
7. Metersky ML, Ma A, Bratzler DW, et al. Predicting bacteremia in patients with community-acquired pneumonia. Am J Respir Crit Care Med. 2004;169:342-347.
8. Tokuda Y, Miyasato H, Stein GH. A simple prediction algorithm for bacteraemia in patients with acute febrile illness. QJM. 2005;98:813-820.
9. Muller F, Christ-Crain M, Bregenzer T, et al. Procalcitonin levels predict bacteremia in patients with community-acquired pneumonia: a prospective cohort trial. Chest. 2010;138:121-129.
10. Schuetz P, Amin DN, Greenwald JL. Role of procalcitonin in managing adult patients with respiratory tract infections. Chest. 2012;141:1063-1073.
11. Schuetz P, Christ-Crain M, Thomann R, et al. Effect of procalcito-nin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA. 2009;302:1059-1066.
12. Schuetz P, Christ-Crain M, Muller B. Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections-hope for hype? Swiss Med Weekly. 2009;139:318-326.
13. Zhydkov A, Christ-Crain M, Thomann R, et al. Utility of procalci-tonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia. Clin Chem Lab Med. 2015;53:559-566.
14. van Nieuwkoop C, Bonten TN, van't Wout JW, et al. Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study. Crit Care. 2010;14:R206.
15. Riedel S, Melendez JH, An AT, et al. Procalcitonin as a marker for the detection of bacteremia and sepsis in the emergency department. Am J Clin Pathol. 2011;135:182-189.
16. Kim MH, Lim G, Kang SY, et al. Utility of procalcitonin as an early diagnostic marker of bacteremia in patients with acute fever. Yonsei Med J. 2011;52:276-281.
17. Schuetz P, Suter-Widmer I, Chaudri A, et al. Prognostic value of procalci-tonin in community-acquired pneumonia. Eur Respir J. 2011;37:384-392.
18. Loonen AJ, de Jager CP, Tosserams J, et al. Biomarkers and molecular analysis to improve bloodstream infection diagnostics in an emergency care unit. PLoS One. 2014;9:e87315.
19. Wyllie DH, Bowler IC, Peto TE. Relation between lymphopenia and bacteraemia in UK adults with medical emergencies. J Clin Pathol. 2004;57:950-955.
20. Yeh CF, Chen KF, Ye JJ, et al. Derivation of a clinical prediction rule for bloodstream infection mortality of patients visiting the emergency department based on predisposition, infection, response, and organ dysfunction concept. J Microbiol Immunol Infect. 2014;47:469-477.
21. Schuetz P, Hausfater P, Amin D, et al. Biomarkers from distinct biological pathways improve early risk stratification in medical emergency patients: the multinational, prospective, observational TRIAGE study. Crit Care (London, England). 2015;19:377.
22. Schuetz P, Hausfater P, Amin D, et al. Optimizing triage and hospitalization in adult general medical emergency patients: the triage project. BMC Emerg Med. 2013;13:12.
23. Thorpe TC, Wilson ML, Turner JE, et al. BacT/Alert: an automated colorimetric microbial detection system. J Clin Microbiol. 1990;28:1608-1612.
24. Schuetz P, Aujesky D, Muller C, et al. Biomarker-guided personalised emergency medicine for all-hope for another hype? Swiss Med Weekly. 2015;145:w14079.
25. Schuetz P, Christ-Crain M, Huber AR, et al. Long-term stability of procalcitonin in frozen samples and comparison of Kryptor and VIDAS automated immunoassays. Clin Biochem. 2010;43:341-344.
26. Schuetz P, Chiappa V, Briel M, et al. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med. 2011;171:1322-1331.
27. de Jager CP, van Wijk PT, Mathoera RB, et al. Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Crit Care (London, England). 2010;14:R192.
28. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Gac Sanit. 2008;22:144-150.
29. Hattori T, Nishiyama H, Kato H, et al. Clinical value of procalcito-nin for patients with suspected bloodstream infection. Am J Clin Pathol. 2014;141:43-51.
30. Arai T, Kumasaka K, Nagata K, et al. Prediction of blood culture results by measuring procalcitonin levels and other inflammatory biomarkers. Am J Emerg Med. 2014;32:330-333.
31. Magrini L, Gagliano G, Travaglino F, et al. Comparison between white blood cell count, procalcitonin and C reactive protein as diagnostic and prognostic biomarkers of infection or sepsis in patients presenting to emergency department. Clin Chem Lab Med. 2014;52:1465-1472.
32. Schuetz P, Litke A, Albrich WC, et al. Blood biomarkers for personalized treatment and patient management decisions in community-acquired pneumonia. Curr Opin Infect Dis. 2013;26:159-167.
33. Howell MD, Talmor D, Schuetz P, et al. Proof of principle: the predisposition, infection, response, organ failure sepsis staging system. Crit Care Med. 2011;39:322-327.
34. Singh M, Koyfman A. What is the role of procalcitonin in early diagnosis of infective endocarditis? Ann Emerg Med. 2015;66:25-26.
35. Schuetz P, Grolimund E, Kutz A, et al. Procalcitonin-guided antibiotic therapy in patients with congestive heart failure and suspicion of lower respiratory tract infection: results from a randomized trial. Crit Care. 2013;17:S12.
36. Schuetz P, Kutz A, Grolimund E, et al. Excluding infection through procalcitonin testing improves outcomes of congestive heart failure patients presenting with acute respiratory symptoms: results from the randomized ProHOSP trial. Int J Cardiol. 2014;175:464-472.